| IPO Company Profile |
| SEC Filings | Peer IPO Companies |
| Orthopaedic Biosystems Ltd, Inc. |
| 15990 N. Greenway-Hayden Loop, Suite 100, Scottsdale, AZ 85260 * (602) 596-4066 |
| The company designs, develops and markets innovative medical devices that are primarily used in orthopaedic surgery, including sports medicine and minimally invasive arthroscopic procedures. |
| Manager | Tier | Phone |
| Cruttenden Roth Incorporated | Lead Manager | (800) 678-9147 |
| Josephthal Lyon & Ross, Inc. | Co-manager | (212) 907-4545 |
| AMEX: | OBL | Manufacturing: | SIC 3842 | |
| Type of Shares: | Common Shares | Filing Date: | 7/1/98 | |
| U.S. Shares Filed: | 2,000,000 | Filing Range: | $6.75 - $7.75 | |
| Non-U.S. Shares Filed: | 0 | Offering Amount: | $14,500,000 | |
| Primary Shares: | 2,000,000 | Expenses: | - | |
| Secondary Shares: | 0 | Post-IPO Shares: | 5,500,000 | |
| Employees: | 19 |
| Issuer's Law Firm: | Snell & Wilmer |
| Bank's Law Firm: | Brobeck, Phleger & Harrison |
| Auditor: | Ernst & Young |
Dollar amounts in U.S. millions except for per share data | |||||
| 3 Month Ending Financials | |||||
| Full Year Audited Income | Latest Unaudited Income | Prior Audited Income | Balance Sheet | ||
| 12/31/97 | 3/31/98 | 3/31/97 | 3/31/98 | ||
| Revenue: | $1.48 | $0.44 | $0.35 | Assets: | $2.28 |
| Net Income: | -$1.39 | -$0.44 | -$0.17 | Curr Assets: | $1.44 |
| EPS: | -$0.33 | -$0.10 | -$0.04 | Liabilities: | $1.23 |
| Prior EPS: | -$0.05 | Curr Liab: | $1.39 | ||
| Cash Flow/Oper: | -$1.97 | -$0.53 | -$0.46 | Equity: | $1.05 |
| Cash Flow/Fin: | $2.58 | $0.05 | $0.11 | Cash: | $0.74 |
| Cash Flow/Inv: | -$0.27 | -$0.12 | -$0.03 | Working Cap: | $0.05 |
| Use of Proceeds |
| The proceeds from the proposed offering will be used for research and development, increased marketing efforts, fund future acquisitions, capital expenditures, repayment of related party indebtedness and working capital and general corporate purposes. |